# FDA Inspection 1291764 - Lianyungang Kangle Pharmaceutical Co., Ltd. - September 19, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/lianyungang-kangle-pharmaceutical-co-ltd/5fd89f40-e966-416a-9bc0-6c6aed69d973
Source feed: FDA_Inspections

> FDA Inspection 1291764 for Lianyungang Kangle Pharmaceutical Co., Ltd. on September 19, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1291764
- Company Name: Lianyungang Kangle Pharmaceutical Co., Ltd.
- Inspection Date: 2025-09-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1291764 - 2025-09-19](https://www.globalkeysolutions.net/records/fda_inspections/lianyungang-kangle-pharmaceutical-co-ltd/d78f33d3-e13d-4ab4-bdd8-f5ba1a4c5cb7)
- [FDA Inspection 1149183 - 2019-05-31](https://www.globalkeysolutions.net/records/fda_inspections/lianyungang-kangle-pharmaceutical-co-ltd/e955ca27-c36e-4cb6-9b3f-f622e4199b4d)
- [FDA Inspection 981645 - 2016-07-15](https://www.globalkeysolutions.net/records/fda_inspections/lianyungang-kangle-pharmaceutical-co-ltd/5b60a867-3752-4db0-b556-1f4586f6ce87)

Company: https://www.globalkeysolutions.net/companies/lianyungang-kangle-pharmaceutical-co-ltd/40be34e0-fb10-4928-81cf-1717686c5d2e

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c